Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -4.03%77.34B | -0.61%80.31B | -12.18%72.18B | 8.08%333.63B | 0.32%90.05B | 5.02%80.59B | 12.53%80.8B | 16.77%82.19B | 2.96%308.69B | 4.75%89.76B |
Cost of revenue | -7.63%56.58B | -3.57%59.51B | -15.88%51.12B | 8.17%250.97B | 0.93%67.24B | 4.31%61.25B | 13.26%61.71B | 16.45%60.77B | 6.54%232.01B | 7.05%66.62B |
Gross profit | 7.37%20.76B | 8.95%20.8B | -1.69%21.06B | 7.79%82.66B | -1.43%22.81B | 7.33%19.33B | 10.21%19.09B | 17.70%21.42B | -6.53%76.68B | -1.34%23.14B |
Operating expense | 16.42%17.55B | 13.50%18.37B | 9.12%17.07B | 11.43%65.29B | 11.20%18.38B | 4.58%15.08B | 12.12%16.18B | 18.44%15.64B | 12.61%58.59B | 16.01%16.53B |
Selling and administrative expenses | 8.05%17.72B | 9.25%17.78B | 9.44%17.2B | 12.15%66.86B | 9.55%18.47B | 12.04%16.4B | 11.19%16.27B | 16.54%15.72B | 13.52%59.62B | 18.72%16.86B |
-General and administrative expense | 8.05%17.72B | 9.25%17.78B | 9.44%17.2B | 12.15%66.86B | 9.55%18.47B | 12.04%16.4B | 11.19%16.27B | 16.54%15.72B | 13.52%59.62B | 18.72%16.86B |
Other operating expenses | 413.89%185M | 430.43%854M | -36.81%103M | 1,353.24%4.94B | 2,693.29%4.58B | -12.20%36M | 147.69%161M | 132.86%163M | -50.44%340M | -54.70%164M |
Total other operating income | -73.81%357M | 5.22%262M | -1.68%234M | 374.65%6.52B | 848.58%4.67B | 414.34%1.36B | -6.04%249M | -32.00%238M | 16.36%1.37B | 56.69%492M |
Operating profit | -24.68%3.21B | -16.39%2.43B | -30.93%3.99B | -3.98%17.38B | -33.03%4.43B | 18.34%4.26B | 0.69%2.91B | 15.72%5.78B | -39.71%18.1B | -28.19%6.61B |
Net non-operating interest income (expenses) | -798.84%-1.2B | 33.23%445M | -86.65%557M | 180.31%4.11B | 93.22%-565M | -99.04%172M | 108.73%334M | 138.35%4.17B | -107.33%-5.12B | 13.06%-8.33B |
Non-operating interest income | -377.65%-1.21B | -31.93%840M | -82.69%745M | 634.75%5.2B | 90.42%-255M | -97.61%434M | 15.43%1.23B | 384.25%4.31B | -99.44%708M | -849.58%-2.66B |
Non-operating interest expense | -101.15%-3M | -56.11%395M | 40.30%188M | -81.30%1.09B | -94.53%310M | 18.55%262M | -81.61%900M | -98.86%134M | -89.80%5.83B | -42.94%5.67B |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | -91.62%97M | -112.16%-172M | -33.30%583M | 48.58%4.14B | 17.40%695M | 9.56%1.16B | 330.09%1.42B | 7.77%874M | 32.78%2.79B | -1.17%592M |
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | -62.39%2.1B | -41.91%2.71B | -52.60%5.13B | 62.59%25.63B | 503.63%4.56B | -75.24%5.59B | 870.25%4.66B | 313.55%10.83B | -84.54%15.76B | -606.28%-1.13B |
Income tax | -80.33%301M | -49.45%778M | -40.79%2.18B | 110.21%9.2B | 577.58%2.45B | -75.77%1.53B | 672.12%1.54B | 418.06%3.68B | -87.16%4.38B | 77.05%-513M |
Net income | -55.61%1.8B | -38.19%1.93B | -58.68%2.95B | 44.29%16.43B | 442.05%2.11B | -75.04%4.06B | 1,028.87%3.12B | 282.64%7.15B | -83.23%11.39B | -125.06%-616M |
Net income continuous operations | -55.63%1.8B | -38.19%1.93B | -58.68%2.95B | 44.29%16.43B | 442.05%2.11B | -75.04%4.06B | 1,028.87%3.12B | 282.64%7.15B | -83.23%11.39B | -125.06%-616M |
Noncontrolling interests | 60.19%346M | -1.08%365M | -30.04%312M | -2.44%1.88B | 56.09%846M | -58.70%216M | -3.40%369M | -6.30%446M | -37.46%1.92B | -24.51%542M |
Net income attributable to the company | -62.12%1.46B | -43.17%1.56B | -60.59%2.64B | 53.78%14.55B | 208.89%1.26B | -75.58%3.84B | 482.75%2.75B | 252.67%6.7B | -85.40%9.46B | -166.55%-1.16B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -62.12%1.46B | -43.17%1.56B | -60.59%2.64B | 53.78%14.55B | 208.89%1.26B | -75.58%3.84B | 482.75%2.75B | 252.67%6.7B | -85.40%9.46B | -166.55%-1.16B |
Gross dividend payment | ||||||||||
Basic earnings per share | -62.16%12.11 | -43.22%13.02 | -60.61%21.99 | 53.73%121.25 | 208.91%10.51 | -75.58%32 | 482.80%22.93 | 252.64%55.82 | -85.25%78.87 | -160.46%-9.65 |
Diluted earnings per share | -62.16%12.11 | -43.22%13.02 | -60.61%21.99 | 53.75%121.23 | 208.70%10.5 | -75.58%32 | 482.80%22.93 | 252.64%55.82 | -85.25%78.85 | -160.68%-9.66 |
Dividend per share | 0 | 0.00%40 | 0 | 2.56%80 | 2.56%40 | 0 | 2.56%40 | 0 | 1.30%78 | 0.00%39 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |